[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.v71.3
|
[2] |
李国新. 胃癌外科2021年研究进展及学科展望[J]. 中华胃肠外科杂志, 2022, 25(1): 15-21.
|
|
LI G X. Research progress and prospect of gastric cancer surgery in 2021[J]. Chin J Gastrointest Surg, 2022, 25(1): 15-21.
|
[3] |
DONG Y P, CAI F L, WU Z Z, et al. Risk of station 12a lymph node metastasis in patients with lower-third gastric cancer[J]. World J Gastrointest Surg, 2021, 13(11): 1390-1404.
doi: 10.4240/wjgs.v13.i11.1390
|
[4] |
SIERRA A, REGUEIRA F M, HERNÁNDEZ-LIZOÁIN J L, et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution[J]. Ann Surg Oncol, 2003, 10(3): 219-226.
pmid: 12679305
|
[5] |
JAPANESE GASTRIC CANCER ASSOCIATION. Japanese gastric cancer treatment guidelines 2018 (5th edition)[J]. Gastric Cancer, 2021, 24(1): 1-21.
doi: 10.1007/s10120-020-01042-y
|
[6] |
JAPANESE GASTRIC CANCER ASSOCIATION. Japanese classification of gastric carcinoma-2nd English edition[J]. Gastric Cancer, 1998, 1(1): 10-24.
doi: 10.1007/PL00011681
|
[7] |
EDGE S B, COMPTON C C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474.
doi: 10.1245/s10434-010-0985-4
pmid: 20180029
|
[8] |
LU J, ZHENG C H, CAO L L, et al. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 7th and 8th editions[J]. Eur J Surg Oncol, 2017, 43(12): 2349-2356.
doi: S0748-7983(17)30659-5
pmid: 28943179
|
[9] |
HARTGRINK H H, VAN DE VELDE C J, PUTTER H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial[J]. J Clin Oncol, 2004, 22(11): 2069-2077.
doi: 10.1200/JCO.2004.08.026
pmid: 15082726
|
[10] |
CUSCHIERI A, WEEDEN S, FIELDING J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group[J]. Br J Cancer, 1999, 79(9/10): 1522-1530.
doi: 10.1038/sj.bjc.6690243
|
[11] |
KONG S H, YOO M W, KIM J W, et al. Validation of limited lymphadenectomy for lower-third gastric cancer based on depth of tumour invasion[J]. Br J Surg, 2011, 98(1): 65-72.
doi: 10.1002/bjs.7266
pmid: 20954197
|
[12] |
WEI Z W, XIA G K, WU Y, et al. Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysis[J]. Hepatogastroenterology, 2013, 60(127): 1789-1796.
|
[13] |
CAI S R, CHEN J H, CHEN C Q, et al. Survival of proper hepatic artery lymph node metastasis in patients with gastric cancer: implications for D2 lymphadenectomy[J]. PLoS One, 2015, 10(3): e0118953.
doi: 10.1371/journal.pone.0118953
|
[14] |
KUMAGAI K, HIKI N, NUNOBE S, et al. Metastasis to the lymph nodes along the proper hepatic artery from adenocarcinoma of the stomach[J]. Langenbecks Arch Surg, 2016, 401(5): 677-685.
doi: 10.1007/s00423-016-1429-9
|
[15] |
IN H, SOLSKY I, PALIS B, et al. Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the national cancer database[J]. Ann Surg Oncol, 2017, 24(12): 3683-3691.
doi: 10.1245/s10434-017-6078-x
pmid: 28895113
|
[16] |
CHEN Z H, LIU Y, DOU L Z, et al. The efficacy of the application of the curative criteria of the 5th edition Japanese gastric cancer treatment guidelines for early adenocarcinoma of the esophagogastric junction treated by endoscopic submucosal dissection[J]. Saudi J Gastroenterol, 2021, 27(2): 97-104.
doi: 10.4103/sjg.SJG_403_20
|
[17] |
AJANI J A, D’AMICO T A, BENTREM D J, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(2): 167-192.
doi: 10.6004/jnccn.2022.0008
|
[18] |
SMITH D D, SCHWARZ R R, SCHWARZ R E. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database[J]. J Clin Oncol, 2005, 23(28): 7114-7124.
doi: 10.1200/JCO.2005.14.621
pmid: 16192595
|
[19] |
SCHWARZ R E, SMITH D D. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage[J]. Ann Surg Oncol, 2007, 14(2): 317-328.
doi: 10.1245/s10434-006-9218-2
pmid: 17094022
|
[20] |
SEEVARATNAM R, BOCICARIU A, CARDOSO R, et al. How many lymph nodes should be assessed in patients with gastric cancer? A systematic review[J]. Gastric Cancer, 2012, 15(Suppl 1): S70-S88.
|
[21] |
张晋杰, 王杰, 胡文庆. 进展期胃上部癌淋巴结清扫的现状与研究进展[J]. 中华胃肠外科杂志, 2018, 21(2): 236-240.
|
|
ZHANG J J, WANG J, HU W Q. Current status and research progress of lymph node dissection in advanced upper gastric cancer[J]. Chin J Gastrointest Surg, 2018, 21(2): 236-240.
|
[22] |
郑民华, 臧潞, 马君俊, 等. SiewertⅡ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2019版)[J]. 中国实用外科杂志, 2019, 39(11): 1129-1135.
|
|
ZHENG M H, ZANG L, MA J J, et al. Endoscopic surgery for SiewertⅡ esophagogastric junction adenocarcinoma in China (2019 edition)[J]. Chin J Pract Surg, 2019, 39(11): 1129-1135.
|
[23] |
SHU P, SUN X F, LIU F L, et al. Pattern of No. 12a lymph node metastasis in gastric cancer[J]. Chin J Cancer Res, 2021, 33(1): 61-68.
doi: 10.21147/j.issn.1000-9604.2021.01.07
|
[24] |
SATO Y, KATAI H, ITO M, et al. Can proximal gastrectomy be justified for advanced adenocarcinoma of the esophagogastric junction?[J]. J Gastric Cancer, 2018, 18(4): 339-347.
doi: 10.5230/jgc.2018.18.e33
pmid: 30607297
|
[25] |
WU G, ZHANG D Y, DUAN Y H, et al. Correlations of hemoglobin level and perioperative blood transfusion with the prognosis of gastric cancer: a retrospective study[J]. Med Sci Monit, 2017, 23: 2470-2478.
doi: 10.12659/MSM.900907
|
[26] |
MITA K, ITO H, KATSUBE T, et al. Prognostic factors affecting survival after multivisceral resection in patients with clinical T4b gastric cancer[J]. J Gastrointest Surg, 2017, 21(12): 1993-1999.
doi: 10.1007/s11605-017-3559-y
|
[27] |
YAMASHITA H, KATAI H, MORITA S, et al. Optimal extent of lymph node dissection for Siewert type Ⅱ esophagogastric junction carcinoma[J]. Ann Surg, 2011, 254(2): 274-280.
doi: 10.1097/SLA.0b013e3182263911
|